Oral candidiasis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Ahmed Younes (talk | contribs)
No edit summary
Ahmed Younes (talk | contribs)
Line 166: Line 166:
*May involve [[skin]], [[lips]], inside the [[mouth]], [[throat]] or [[esophagus]]
*May involve [[skin]], [[lips]], inside the [[mouth]], [[throat]] or [[esophagus]]
|
|
* Chronic sun or [[UV exposure]]
* Chronic sun or [[Ultraviolet|UV exposure]]
* Fair [[skin]]
* Fair [[skin]]
* [[Elderly]] age (>45 yrs)
* [[Elderly]] age (>45 yrs)
Line 188: Line 188:
|[[Leukoplakia]]
|[[Leukoplakia]]
|
|
*White leathery spots on the mucous membranes of the [[tongue]] and inside of the [[mouth]]
*White leathery spots on the [[mucous membranes]] of the [[tongue]] and inside of the [[mouth]]
*Lateral borders of [[tongue]]
*Lateral borders of [[tongue]]
|
|
Line 200: Line 200:
*[[Biopsy]]
*[[Biopsy]]
|
|
*Vulvar lesions occur independent of oral lesions
*[[Vulva|Vulvar]] lesions occur independent of oral lesions
|
|
*Associated with [[HIV]]
*Associated with [[HIV]]
*Persistant white spots
*Persistant white spots
*[[Benign]] but can progress to [[carcinoma]] after almost 10 years
*[[Benign]] but can progress to [[carcinoma]] after almost 10 years
*Oral proliferative [[verrucous leukoplakia]] is an aggressive sub type with multiple lesions and higher conversion to [[warts]] or [[carcinoma]]<ref>{{Cite journal
*Oral proliferative [[Leukoplakia|verrucous leukoplakia]] is an aggressive sub type with multiple lesions and higher conversion to [[warts]] or [[carcinoma]]<ref>{{Cite journal
  | author = [[Ann M. Gillenwater]], [[Nadarajah Vigneswaran]], [[Hanadi Fatani]], [[Pierre Saintigny]] & [[Adel K. El-Naggar]]
  | author = [[Ann M. Gillenwater]], [[Nadarajah Vigneswaran]], [[Hanadi Fatani]], [[Pierre Saintigny]] & [[Adel K. El-Naggar]]
  | title = Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
  | title = Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
Line 228: Line 228:
*[[Bleeding]] from the lesion
*[[Bleeding]] from the lesion
|
|
*[[UV radiations]]
*[[Ultraviolet|UV radiations]]
*[[Genetic predisposition]]
*[[Genetic predisposition]]
*[[Old age]]
*[[Old age]]
Line 244: Line 244:
*1-2 to hundreds of [[granules]]
*1-2 to hundreds of [[granules]]
|
|
*[[Neural crest cell derivative]]
*[[Neural crest cell]] derivative
*Development begins with disruption of nevus growth control
*Development begins with disruption of [[nevus]] growth control
*Progression involves [[MAPK/ERK pathway]]
*Progression involves [[MAPK/ERK pathway]]
*[[N-RAS]] or [[BRAF]] oncogene also involved
*[[RAS|N-RAS]] or [[BRAF]] [[oncogene]] also involved
|[[File:Melanoma oral 001a.jpg|Oral melanoma|400x400px]]
|[[File:Melanoma oral 001a.jpg|Oral melanoma|400x400px]]
|-
|-
Line 257: Line 257:
|
|
*Greasy skin types
*Greasy skin types
*Some [[rheumatic disorders]]
*Some [[Rheumatic|rheumatic disorders]]
*[[Hereditary nonpolyposis colorectal cancer]]
*[[Hereditary nonpolyposis colorectal cancer]]
**Lower [[gingiva]] (gums)  
**Lower [[gingiva]] (gums)  
**[[Vestibular mucosa]]
**[[Vestibular system|Vestibular mucosa]]
|
|
*[[Physical exam]]
*[[Physical exam]]
*Small [[keratin]]-filled [[pseudocysts]]
*Small [[keratin]]-filled [[pseudocysts]]
*May be seen on [[incidental]] mucosal [[biopsy]]
*May be seen on [[incidental]] [[mucosal]] [[biopsy]]
**[[Biopsy]] not done for them primarily
**[[Biopsy]] not done for them primarily
|
|
*[[Oral cavity]]
*[[Oral cavity]]
**Vermilion border of the lips
**[[Vermillion border|Vermilion border]] of the lips
**[[Oral mucosa]] of the upper lip
**[[Oral mucosa]] of the upper lip
*[[Buccal mucosa]] in the commissural region often bilaterally
*[[Buccal mucosa]] in the commissural region often bilaterally
Line 275: Line 275:
*[[Benign neoplasms]] with [[sebaceous]] features
*[[Benign neoplasms]] with [[sebaceous]] features
*Visible [[sebaceous glands]]
*Visible [[sebaceous glands]]
*No surrounding mucosal change
*No surrounding [[mucosal]] change
*Several adjacent [[glands]] may coalesce into a larger cauliflower-like cluster
*Several adjacent [[glands]] may coalesce into a larger cauliflower-like cluster
|[[File:Fordyce spots 02a.jpg|Fordyce spots|400x400px]]
|[[File:Fordyce spots 02a.jpg|Fordyce spots|400x400px]]
Line 284: Line 284:
|
|
*[[Nutritional deficiencies]]
*[[Nutritional deficiencies]]
*Chronic [[anxiety]] or [[depression]
*Chronic [[anxiety]] or [[depression]]
*[[Diabetes type 2]]
*[[Diabetes type 2]]
*[[Menopause]]
*[[Menopause]]
Line 310: Line 310:
*[[Physical exam]]
*[[Physical exam]]
*Types
*Types
**Flat tori
**[[Torus palatinus|Flat tori]]
**Spindle tori
**[[Torus palatinus|Spindle tori]]
**Nodular tori  
**[[Torus palatinus|Nodular tori]]
**Lobular tori  
**[[Torus palatinus|Lobular tori]]
|
|
*[[Hard palate]]
*[[Hard palate]]
Line 347: Line 347:
*[[GIT]]
*[[GIT]]
*[[Eye]]
*[[Eye]]
*[[Joints]
*[[Joints]]
*[[Skin]]
*[[Skin]]
*[[Vascular system]]
*[[Vascular system]]
Line 358: Line 358:
|[[Crohn's disease]]
|[[Crohn's disease]]
|
|
*Chronic, [[episodic diarrhea]] or [[constipation]]
*Chronic, episodic [[diarrhea]] or [[constipation]]
*[[Abdominal pain]]
*[[Abdominal pain]]
*[[Vomiting]]
*[[Vomiting]]
Line 371: Line 371:
*Typical [[history]] and [[symptoms]]
*Typical [[history]] and [[symptoms]]
*[[Skip lesions]] on [[biopsy]]
*[[Skip lesions]] on [[biopsy]]
*Anti-[[Saccharomyces cerevisiae antibodies]] ([[ASCA]])
*[[Anti saccharomyces cerevisiae antibodies|Anti-Saccharomyces cerevisiae antibodies (ASCA)]]
*[[Anti-neutrophil cytoplasmic antibodies]] ([[ANCA]])
*[[Anti-neutrophil cytoplasmic antibodies]] ([[ANCA]])
|
|
Line 410: Line 410:
*[[Conjunctiva]]
*[[Conjunctiva]]
|
|
*[[Immunocompromization]]
*[[Immunocompromised|Immunocompromization]]
*Types
*Types
**[[Drug-induced]]
**[[Drug-induced]]
Line 425: Line 425:
*Illicit [[drug use]]
*Illicit [[drug use]]
*[[Unprotected sex]]
*[[Unprotected sex]]
*[[Men who have sex with men]]
*[[Homosexual men|Men who have sex with men]]
*Residence in highly prevalent areas
*Residence in highly prevalent areas
*[[Human Immunodeficiency Virus (HIV)|HIV]] infection
*[[Human Immunodeficiency Virus (HIV)|HIV]] infection
*Presence of other [[STI]]s
*Presence of other [[STI]]s
*Previous history of STIs
*Previous history of [[Sexually transmitted disease|STIs]]
*[[Intravenous drug use]]
*[[Intravenous drug use]]
|
|
*[[Darkfield microscopy]]
*[[Darkfield microscope|Darkfield microscopy]]
*[[Nontreponemal tests]] like [[VDRL]] and [[RPR test]])  
*Non [[Treponema|treponemal]] tests like [[VDRL]] and [[RPR test]])  
*[[Treponemal tests[[ [[FTA-ABS tests]], (TP-PA) assay, [[Enzyme linked immunosorbent assay (ELISA)|enzyme immunoassays]], and [[Chemiluminescence|chemiluminescence immunoassays]])
*[[Treponema|Treponemal]] tests[[FTA-ABS|FTA-ABS tests]], (TP-PA) assay, [[Enzyme linked immunosorbent assay (ELISA)|enzyme immunoassays]], and [[Chemiluminescence|chemiluminescence immunoassays]])
|
|
*[[Oral cavity]]
*[[Oral cavity]]
Line 443: Line 443:
*[[Rectum ]]
*[[Rectum ]]
*[[CNS]]
*[[CNS]]
*[[CVS]]
*[[Cardiovascular|CVS]]
|
|
*[[Primary syphilis]]
*[[Primary syphilis]]
**[[Chancre]]
**[[Chancre]]
*[[Secondary syphilis]]
*[[Secondary syphilis]]
**[[Condylomata lata]]
**[[Condyloma latum|Condylomata lata]]
*[[Latent syphilis]]
*[[Latent syphilis]]
**[[Asymptomatic]]
**[[Asymptomatic]]
*[[Tertiary syphilis]]
*[[Tertiary syphilis]]
**[[Gummas]]
**[[Gumma|Gummas]]
**[[Neurosyphilis]]
**[[Neurosyphilis]]
|[[File:Syphilis orala.jpg|oral syphilis|400x400px]]
|[[File:Syphilis orala.jpg|oral syphilis|400x400px]]
Line 479: Line 479:
|[[Chickenpox|Chicken pox]]
|[[Chickenpox|Chicken pox]]
|
|
*[[Conjunctival symptoms]]
*Conjunctival symptoms
*[[Catarrhal symptoms]]
*Catarrhal symptoms  
*Characteristic [[spots]] on the trunk appearing in two or three waves
*Characteristic [[spots]] on the trunk appearing in two or three waves
*[[Itching]]
*[[Itching]]
Line 490: Line 490:
|
|
*[[History]] and [[physical exam]]
*[[History]] and [[physical exam]]
*[[PCR]] to detect [[VZV]] in [[skin lesions]] ([[vesicles]], [[scabs]], [[maculopapular lesions]])
*[[PCR]] to detect [[VZV]] in [[skin lesions]] ([[vesicles]], [[scabs]], [[Maculopapular|maculopapular lesions]])
|
|
*[[Oral cavity]]
*[[Oral cavity]]
Line 543: Line 543:
[[Category:Primary care]]
[[Category:Primary care]]
{{WH}}
{{WH}}
{{WS}}|}|}
{{WS}}|}|}|}

Revision as of 21:41, 10 May 2017

Oral candidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Oral candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oral candidiasis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oral candidiasis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oral candidiasis differential diagnosis

CDC on Oral candidiasis differential diagnosis

Oral candidiasis differential diagnosis in the news

Blogs on Oral candidiasis differential diagnosis

Directions to Hospitals Treating Oral candidiasis

Risk calculators and risk factors for Oral candidiasis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Ahmed Younes M.B.B.CH [2]

Overview

Oropharyngeal candidiasis must be differentiated from its different kinds and from various other diseases that can cause stomatitis or glossitis

Differential diagnosis

Oropharyngeal candidiasis must be differentiated from its different kinds and from various other diseases that can cause stomatitis or glossitis:[1][2]

Disease Presentation Risk Factors Diagnosis Affected Organ Systems Important features Picture
Diseases predominantly affecting the oral cavity
Oral Candidiasis
  • Denture users
  • As a side effect of medication, most commonly having taken antibiotics. Inhaled corticosteroids for treatment of lung conditions (e.g, asthma or COPD) may also result in oral candidiasis which may be reduced by regularly rinsing the mouth with water after taking the medication.
  • Clinical diagnosis
  • Confirmatory tests rarely needed
Localized candidiasis

Invasive candidasis

Tongue infected with oral candidiasis - By James Heilman, MD - Own work, CC BY-SA 3.0, httpscommons.wikimedia.orgwindex.phpcurid=11717223.jpg
Herpes simplex oral lesions
  • Stress
  • Recent URTI
  • Female sex
  • The symptoms of primary HSV infection generally resolve within two weeks
Oral herpes simplex infection - By James Heilman, MD - Own work, CC BY-SA 3.0, httpscommons.wikimedia.orgwindex.phpcurid=19051042.jpg
Aphthous ulcers
  • Painful, red spot or bump that develops into an open ulcer
  • Physical examination
  • Diagnosis of exclusion
  • Oral cavity
  • Self-limiting , Pain decreases in 7 to 10 days, with complete healing in 1 to 3 weeks
By Ebarruda - Own work, CC BY-SA 3.0, httpscommons.wikimedia.orgwindex.phpcurid=7903358
Squamous cell carcinoma Squamous cell carcinoma
Leukoplakia
  • Vulvar lesions occur independent of oral lesions
Leukoplakia
Melanoma Oral melanoma
Fordyce spots Fordyce spots
Burning mouth syndrome
Torus palatinus Torus palatinus
Diseases involving oral cavity and other organ systems
Behcet's disease Behcet's disease
Crohn's disease
Agranulocytosis
Syphilis[11] oral syphilis
Coxsackie virus
  • Symptomatic treatment
Hand-foot-and-mouth disease
Chicken pox
  • Conjunctival symptoms
  • Catarrhal symptoms
  • Characteristic spots on the trunk appearing in two or three waves
  • Itching
Chickenpox
Measles Koplick spots (Measles)


References

  1. Mandell; Gouglas, Gordon; Bennett, John. Principles and Practice of Infectious Diseases. Harvard Medical School: WILEY MEDICAL. p. 383. ISBN 0-471-87643-7. Unknown parameter |firs1t= ignored (help)
  2. Scully C (1999). "A review of common mucocutaneous disorders affecting the mouth and lips". Ann Acad Med Singapore. 28 (5): 704–7. PMID 10597357.
  3. R. Morgan, J. Tsang, N. Harrington & L. Fook (2001). "Survey of hospital doctors' attitudes and knowledge of oral conditions in older patients". Postgraduate medical journal. 77 (908): 392–394. PMID 11375454. Unknown parameter |month= ignored (help)
  4. D. Grady, J. Greene, T. E. Daniels, V. L. Ernster, P. B. Robertson, W. Hauck, D. Greenspan, J. Greenspan & S. Jr Silverman (1990). "Oral mucosal lesions found in smokeless tobacco users". Journal of the American Dental Association (1939). 121 (1): 117–123. PMID 2370378. Unknown parameter |month= ignored (help)
  5. P. DeMatos, D. S. Tyler & H. F. Seigler (1998). "Malignant melanoma of the mucous membranes: a review of 119 cases". Annals of surgical oncology. 5 (8): 733–742. PMID 9869521. Unknown parameter |month= ignored (help)
  6. Barry Ladizinski & Kachiu C. Lee (2014). "A nodular protuberance on the hard palate". JAMA. 311 (15): 1558–1559. doi:10.1001/jama.2014.271. PMID 24737369. Unknown parameter |month= ignored (help)
  7. Magliocca KR, Fitzpatrick SG (2017) Autoimmune Disease Manifestations in the Oral Cavity. Surg Pathol Clin 10 (1):57-88. DOI:10.1016/j.path.2016.11.001 PMID: 28153136
  8. Dalghous AM, Freysdottir J, Fortune F (2006). "Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD". Scand J Rheumatol. 35 (6): 472–5. PMID 17343257.
  9. Ann M. Gillenwater, Nadarajah Vigneswaran, Hanadi Fatani, Pierre Saintigny & Adel K. El-Naggar (2013). "Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!". Advances in anatomic pathology. 20 (6): 416–423. doi:10.1097/PAP.0b013e3182a92df1. PMID 24113312. Unknown parameter |month= ignored (help)
  10. Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. (2006). "Idiosyncratic drug-induced agranulocytosis: Update of an old disorder". Eur J Intern Med. 17 (8): 529–35. Text "pmid 17142169" ignored (help)
  11. title="By Internet Archive Book Images [No restrictions], via Wikimedia Commons" href="https://commons.wikimedia.org/wiki/File%3AA_manual_of_syphilis_and_the_venereal_diseases%2C_(1900)_(14595882378).jpg"
  12. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE (2000). "Individual and community risks of measles and pertussis associated with personal exemptions to immunization". JAMA. 284 (24): 3145–50. PMID 11135778.
  13. Ratnam S, West R, Gadag V, Williams B, Oates E (1996). "Immunity against measles in school-aged children: implications for measles revaccination strategies". Can J Public Health. 87 (6): 407–10. PMID 9009400.

Template:WH Template:WS|}|}|}